3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
228
Leukemia, Lymphocytic, Chronic, B-Cell
211
Leukemia
201
Myelodysplastic Syndromes
184
Precursor Cell Lymphoblastic Leukemia-Lymphoma
172
Lymphoma
147
Lymphoma, Non-Hodgkin
141
Multiple Myeloma
130
Hodgkin Disease
121
Lymphoma, Follicular
110
Lymphoma, Mantle-Cell
107
Lymphoma, Large B-Cell, Diffuse
95
Lymphoma, B-Cell, Marginal Zone
88
Myeloproliferative Disorders
86
Congenital Abnormalities
84
Burkitt Lymphoma
84
Leukemia, Myelomonocytic, Chronic
77
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
75
Leukemia, Myeloid, Chronic-Phase
74
Leukemia, Myeloid, Accelerated Phase
72
Recurrence
62
Melanoma
62
Lymphoma, Large-Cell, Immunoblastic
60
Anemia, Refractory, with Excess of Blasts
60
Primary Myelofibrosis
55
Neoplasms, Plasma Cell
55
Waldenstrom Macroglobulinemia
54
Blast Crisis
54
Hematologic Neoplasms
44
Lymphoma, T-Cell, Cutaneous
42
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Chickenpox
×
fludarabine phosphate
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled